Company intelligence / Profile preview
Raymed Pharmaceuticals
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
Overview
Raymed Pharmaceuticals has commercialized over 80 products, mostly focused on ophthalmic (eye care) solutions such as preservative-free eye drops, lubricants, antioxidants, and vitamin supplements, with a significant market presence in India and international regulatory accreditations.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculeBiologicPeptidesAntioxidantsVitaminsMinerals
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Raymed Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Raymed Pharmaceuticals.